✅ New API: 6000+ US Stock Options End-of-Day Data with 40+ fields. Learn more

LISATA THERAP.INC.DL-001 (8NE F) stock market data APIs

€1.8249 0(0%)
as of September 12, 2025
Try our APIs with free plan!

LISATA THERAP.INC.DL-001 Financial Data Overview

Price chart is built with Anychart

Lisata Therapeutics, Inc., a clinical-stage pharmaceutical company, engages in the discovery, development, and commercialization of therapies for the treatment of solid tumors and other diseases. Its investigational product is certepetide, which is in Phase 2 clinical studies for the treatment of solid tumors, such as metastatic pancreatic ductal adenocarcinoma, cholangiocarcinoma, appendiceal cancer, and colon cancer and glioblastoma multiforme in combination with a range of anti-cancer regimens. The company was incorporated in 1980 and is headquartered in Basking Ridge, New Jersey.

Prev. Close 1.8249
Open 1.8249
High 1.8249
Low 1.8249
52 wk Range 1.64-3.66
Market Cap 16 760 K
Shares Outstanding 8 756 K
Revenue 1 070 K
Beta 1.013

* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.


ETFs with LISATA THERAP.INC.DL-001 (top by weight)

Ticker
100-day Price Change
Weight
VTI.US Vanguard Total Stock Market Index Fund ETF Shares
30.08 (10.22%)
0.00
VXF.US Vanguard Extended Market Index Fund ETF Shares
20.76 (11.04%)
0.00

* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.


Why to choose EODHD?

Prices start at $19.99

24/7 Live support

Robust, powerful and reliable data

API Simplicity of a few lines of code


Try our APIs
with free plan!

Or get access to advanced financial data starting only $19.99

TRY NOW

Get LISATA THERAP.INC.DL-001 data using free add-ons & libraries


Get LISATA THERAP.INC.DL-001 Fundamental Data

LISATA THERAP.INC.DL-001 Fundamental data includes:

  • Net Revenue: 1 070 K
  • EBITDA: -20 831 000
  • Earnings Per Share:
  • Income Statements
  • Balance Sheets
  • Cash flows

Plans with Fundamental data

Starting from

$ 59.99 /mo.
COMPARE PLANS

End-of-day & Earnings data

Get LISATA THERAP.INC.DL-001 Earnings data

Calendar & News package for

$ 19.99 /mo.

What’s included:

  • Latest Release: NaN
  • EPS/Forecast: NaN
GET THE PACKAGE

Get LISATA THERAP.INC.DL-001 End-of-day data

EOD Historical Data package for

$ 19.99 /mo.

What’s included:

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends
GET THE PACKAGE
Try our APIs
with free plan!

Or get access to advanced financial data starting only $19.99

TRY NOW
  • Flexibility: No long-term commitments, just a minimum of one month
  • Instant access: Get your API key and instructions within seconds of subscribing
  • Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.

What’s included:

  • API Calls per Day: 100 000/day
  • API Requests per Min.: 1000/minute
  • Type of Usage: Personal use

Data access:

Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.

GET THE PACKAGE
Chat